chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash; This case was reported by a consumer via  interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of rash (1st dose received in 2019, refer case US2021AMR180459).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient received Shingles vaccine and experienced persistent rash since than. The patient get to went away, then it pops up somewhere else. The reporter said it was terrible but still better than shingles. The follow up would not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180459:Same patient, different dose
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Pruritus
Clinical narrative: Same here/ shingles; itch; Pain; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received old shingles vaccine, 7 years ago and was fine).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles, pruritus and pain. On an unknown date, the outcome of the shingles, pruritus and pain were unknown.   It was unknown if the reporter considered the shingles, pruritus and pain to be related to Shingles vaccine.  Additional details were provided are as follows: The age at vaccination was not reported. The patient received Shingles vaccine and got shingles a couple of days later after the new vaccine with itch and pain. The reporter asked if he/she went back for the second dose. The follow up would not be possible as no contact details were available. The case was linked with case US2021AMR170346 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR170346:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: Felt terrible worse than the COVID shot; This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (patient's father had it on face and suffered till he passed). Previously administered products included Covid vaccine (received COVID shot on an unknown date).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feels awful. On an unknown date, the outcome of the feels awful was unknown.   It was unknown if the reporter considered the feels awful to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The patient received 1st shingles shot  and felt terrible worse than the COVID shot. The reporter asked that the 2nd shingles shot was worse or not as bad. The follow up would not be possible as no contact details were available. The case was linked with case US2021AMR180720 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180720:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Accidental overdose, Extra dose administered
Clinical narrative: overdose; This case was reported by a other health professional via interactive digital media (Shingrix chatbot) and described the occurrence of accidental overdose in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced accidental overdose. On an unknown date, the outcome of the accidental overdose was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient inadvertently received 2 doses of Shingrix, which led to accidental overdose.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site pain
Clinical narrative: excruciating pain in my arm from the injection site to my shoulder; Shoulder pain; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced injection site pain and shoulder pain. On an unknown date, the outcome of the injection site pain and shoulder pain were unknown.   It was unknown if the reporter considered the injection site pain and shoulder pain to be related to Shingles vaccine.  Additional details were provided as follows: The case reported by the patient himself/herself. The age at vaccination was not reported. The patient received the 2nd dose of Shingles vaccine 18 months before reporting date and it left patient in excruciating pain in my arm from the injection site to my shoulder. The reporter stated his/her experience was very traumatic. The reporter stated that he/she could not take take it anymore and doctor referred patient to an orthopedist and mentioned he/she did not know what they would find.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: injection site is red; injection site swollen; injection site hot to the touch; This case was reported by a consumer via interactive digital media SHINGRIX and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th August 2021 09:30, the patient received the 1st dose of Shingrix. In August 2021, 33 hrs after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site warmth were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not reported. The reporter stated that, the patient received the 1st dose of Shingrix vaccination the day before reporting date at 9:30 am and 33hours after the vaccination the patient's injection site was very hot to the touch. The patient also experienced red and swollen injection site. The reporter stated that the events did not worry him/her and asked could he/she ice that area.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: arm where vaccinated red; arm where vaccinated sore; arm where vaccinated swollen; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema, injection site pain and injection site swelling. On an unknown date, the outcome of the injection site erythema, injection site pain and injection site swelling were unknown.   It was unknown if the reporter considered the injection site erythema, injection site pain and injection site swelling to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received 1st dose of Shingrix vaccine and the patient asked how long should the arm where vaccinated stay red, sore or swollen. No contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: Sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes Zoster (shingles vaccines) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient got the shingles vaccine and was so sick.
Sex: U
Vaccine: VARZOS
Symptoms: Contusion, Pain
Clinical narrative: Sore; bruised; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th August 2021, the patient received Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced pain and contusion. On an unknown date, the outcome of the pain and contusion were not recovered/not resolved.   It was unknown if the reporter considered the pain and contusion to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The patient received a Shingles vaccine shot 3 days ago and still had sore and bruised. The follow up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The patient had shingles shots twice, and still got shingles. The patient had shingles now. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: Ill; This case was reported by a consumer via interactive digital media and described the occurrence of unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. On an unknown date, the outcome of the unwell was unknown.   It was unknown if the reporter considered the unwell to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient received shingles vaccine and was ill. The reporter did not consented to followup as no patient details reported.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Headache, Myalgia, Throat tightness
Clinical narrative: Severe headaches; Hives; Muscle pain; Joint pain; Chills; Sight tightness in throat; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th August 2021, the patient received the 1st dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced headache, hives, muscle pain, joint pain, chills and throat tightness. On an unknown date, the outcome of the headache, hives, muscle pain, joint pain, chills and throat tightness were not recovered/not resolved.   It was unknown if the reporter considered the headache, hives, muscle pain, joint pain, chills and throat tightness to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix and experienced severe headaches, hives, muscle and joint pain, chills and a slight tightness in the throat. The patient asked if he/she should get the second shot and when it is due. Follow-up would not be possible as no contact details available.
Sex: U
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Severe headaches; Hives; Muscle pain; Joint pain; Chills; Sight tightness in throat; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th August 2021, the patient received the 1st dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced headache, hives, muscle pain, joint pain, chills and throat tightness. On an unknown date, the outcome of the headache, hives, muscle pain, joint pain, chills and throat tightness were not recovered/not resolved.   It was unknown if the reporter considered the headache, hives, muscle pain, joint pain, chills and throat tightness to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix and experienced severe headaches, hives, muscle and joint pain, chills and a slight tightness in the throat. The patient asked if he/she should get the second shot and when it is due. Follow-up would not be possible as no contact details available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles / got the shot, broke out with shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle shot a couple years ago on the 6th May and broke out with shingles on the 26th of May. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule and laboratory test confirming shingles were unknown at the time of reporting. Note: As the year when the patient received vaccine and when the patient experienced event was not reported, thus considering the worst case event suspected vaccination failure was captured in the case.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Neuralgia, Rash, Vaccination failure
Clinical narrative: 2 months after shot got shingles\Suspected vaccination failure; Got shingles; Rash is gone; Pain is there on the tip of the nerves; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash and nerve pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the rash was recovered/resolved and the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, rash and nerve pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shot and about 2 months later a got shingles that was in 2020 rash was gone now pain was still there and very painful, physician said might be painful up to 5 years. It was on the tip of the nerves. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Immune system disorder, Incomplete course of vaccination, Nervous system disorder
Clinical narrative: Immune system went on overload; Neurological side effects; not get the second one no way; This case was reported by a consumer via interactive digital media and described the occurrence of immune system disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis (severe).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced immune system disorder, nervous system disorder and incomplete course of vaccination. On an unknown date, the outcome of the immune system disorder, nervous system disorder and incomplete course of vaccination were unknown.   The reporter considered the immune system disorder and nervous system disorder to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported for 1st dose and not applicable for 2nd dose. The patient takes immune suppressant drugs. The patient stated his/her immune system went on overload and had neurological side effects from the 1st Shingrix vaccine. The patient stated that he/she would not get the second one, which led to incomplete course of vaccination. The follow up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pruritus, Vaccination failure
Clinical narrative: took the Vacination before I had shingles/Suspected Vaccination failure; had shingles 2 times over about 10 months. I have it now; itches so bad; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pruritus. The patient was treated with steroids nos (Steroid Shot (Nos)), nystatin and benadryl (nos) (Benadryl Cream). On an unknown date, the outcome of the vaccination failure and pruritus were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The patient took Shingrix vaccination before he/she had shingles ever before. The patient had shingles 2 times over about 10 months and patient still had it now and it itches so bad it drives patient crazy. The patient just left doctor office and got the steroid shot and prescriptions for some steroid pills, a tube of something that must had nystatin in it because it burned him/her so  bad it was like a hot fire, so at the pharmacy the patient picked up some Benadryl cream and tablet which should help to him/her soon. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting. For the tolerance of Nystatin refer case US2021AMR183383, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183383:Pharma case
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Susspected Vaccination failure; shingles; pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got both the Shingles shots last year but at the time of reporting, the patient had the worst shingles out break and the patient was in so much pain. The patient did not wish them on anybody. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation for shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected Vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter knew the patient who had the Shingles shot but still got the shingles. The reporter heard that anyone could get shingles, however, it was not supposed to be as bad. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: same thing happened to my sister in law after the vaccine she got it/ suspected vaccination failure; same thing happened to my sister in law after the vaccine she got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was the sister in law of the reporter. The age at vaccination was not reported. The patient received Shingles vaccine and got the shingles. The reporter still believe adults would be better off with another chicken pox shot. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting. This case had been linked with US2021AMR182882, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR182882:IDM response comment
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: got the first shot. Later I got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient stated that, got the shingles vaccine and later got shingles. The patient was told they would have been worse. The patient did not consented to follow up as no patient details provided. For second dose refer case US2021AMR183410,Same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183410:Same reporter
Sex: U
Vaccine: COVID19, VARZOS, VARZOS, COVID19, VARZOS, VARZOS
Symptoms: COVID-19, Herpes zoster, Vaccination failure
Clinical narrative: Broke out with shingles; Covid infection; Suspected vaccination failure; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and COVID-19 VACCINE for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine, the 1st dose of Shingles vaccine and the 1st dose of COVID-19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant), shingles (serious criteria hospitalization) and covid-19 (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, shingles and covid-19 were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and covid-19 to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient was in the hospital with Covid and broke out with shingles. The patient had had both shots and was told, he/she would still get them. He/she received first Covid shot and broke out with shingles again.  The patient was told not to get second Covid shot. This case was considered as suspected vaccination failure, since the details regarding time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: COVID19, VARZOS, VARZOS, COVID19, VARZOS, VARZOS
Symptoms: COVID-19, Herpes zoster, Pain, Vaccination failure
Clinical narrative: Broke out with shingles; Covid infection; Suspected vaccination failure; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and COVID-19 VACCINE for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine, the 1st dose of Shingles vaccine and the 1st dose of COVID-19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant), shingles (serious criteria hospitalization) and covid-19 (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure, shingles and covid-19 were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and covid-19 to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient was in the hospital with Covid and broke out with shingles. The patient had had both shots and was told, he/she would still get them. He/she received first Covid shot and broke out with shingles again.  The patient was told not to get second Covid shot. This case was considered as suspected vaccination failure, since the details regarding time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Headache, Herpes zoster, Pain, Vaccination failure
Clinical narrative: Suspected vaccination failure; have Shingles on the back of my head; very painful headaches; very painful headaches; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and headache. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, pain and headache were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and headache to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows The patient had reported this case. The age at vaccination was not reported. The patient received both the doses of Shingles vaccine last year from the date of reporting. The patient went to see the doctor on 26th August 2021 and had shingles on the back of head and very painful headache. This case was considered as suspected vaccination failure, since the details regarding time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles twice. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles very bad; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got very bad shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; very mild case of it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The case was reported for the reporter's husband. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got very mild of shingles. The reporter stated that, it was worth the vaccine and suggested to get the Shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Deafness unilateral
Clinical narrative: deaf in my left ear; This case was reported by a consumer via media and described the occurrence of deafness unilateral in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced deafness unilateral (serious criteria GSK medically significant). On an unknown date, the outcome of the deafness unilateral was unknown.   The reporter considered the deafness unilateral to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient stated that, Shingles vaccine made him/her deaf in left ear.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for himself/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Discomfort, Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles / got the vaccine a few years ago and got the shingles; Not comfortable at all.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and discomfort. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the discomfort was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and discomfort to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle vaccine a few years ago and got the shingles last winter.  The patient was not comfortable at all. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule and laboratory test confirming shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; had shingle flare ups / got the vaccine/ had shingle flare ups since then; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient never had shingles but through the advice of the doctor because of the patients age got the vaccine and had shingle flare ups since then. The reporter stated that like any other vaccine it effected each person differently due to a lot of variables. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case is one of the 4 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184332:same reporter US-GLAXOSMITHKLINE-US2021AMR184305:Same reporter US-GLAXOSMITHKLINE-US2021AMR184304:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles three times. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; had shingle flare ups; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The age at vaccination was not reported. The patient never had shingles but through the advice of their doctor because of his/her age got the Shingles vaccine. Since receiving Shingles vaccine, the patient got had shingles flare ups. The reporter stated that, like any other vaccine, if effects each person differently due to a lot of variables. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. This is 1 of 4 linked case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184294:Same reporter US-GLAXOSMITHKLINE-US2021AMR184305:Same reporter US-GLAXOSMITHKLINE-US2021AMR184332:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; had shingle flare ups; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The age at vaccination was not reported. The patient never had shingles but through the advice of their doctor because of his/her age got the Shingles vaccine. Since receiving Shingles vaccine, the patient had shingles flare ups. The reporter stated that, like any other vaccine, if effects each person differently due to a lot of variables. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. This is 1 of 4 linked case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184304:Same reporter US-GLAXOSMITHKLINE-US2021AMR184294:Same reporter US-GLAXOSMITHKLINE-US2021AMR184332:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; PHN; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient received shingles vaccine and still experienced  a severe case of shingles and still suffer from PHN (Post herpetic neuralgia) years later. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.